- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis, Secondary Progressive in United Kingdom
Total 1528 results
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam UniversityCompletedMultiple SclerosisUnited Kingdom
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
Nottingham University Hospitals NHS TrustUnknown
-
Queen Mary University of LondonBiogen; Barts & The London NHS Trust; Moorfields Eye Hospital NHS Foundation... and other collaboratorsRecruitingMultiple Sclerosis | Clinically Isolated Syndrome of DemyelinationUnited Kingdom
-
University of EdinburghNHS LothianEnrolling by invitationMultiple SclerosisUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustJP Moulton Charitable FoundationCompleted
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
City, University of LondonUniversity College London HospitalsCompletedMultiple SclerosisUnited Kingdom
-
Institute for Clinical ResearchUnknownRelapsing-Remitting Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
Celestra Health SystemsBrigham and Women's Hospital; The Ottawa Hospital; Barts & The London NHS Trust; University of OttawaRecruitingMultiple SclerosisUnited States, Canada, United Kingdom
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Medical Research CouncilCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisRussian Federation, United States, Canada, Poland
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
University of LouisvilleRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Johns Hopkins UniversityGlaxoSmithKlineTerminatedMultiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisPoland, Hungary, United States, Czech Republic
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
University of MichiganCompleted
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Queen Mary University of LondonActive, not recruiting
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Rocky Mountain MS Research Group, LLCBiogenCompletedRelapsing Remitting Multiple SclerosisUnited States
-
MSDx, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
OhioHealthCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
University of Wisconsin, MadisonCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Alabama Neurology Associates, PCBiogenUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Multiple Sclerosis InstituteUnknown
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | Neuropathic PainUnited Kingdom
-
Queen Margaret UniversityNHS LothianCompletedMultiple SclerosisUnited Kingdom
-
Jazz PharmaceuticalsCompletedPain | Multiple SclerosisUnited Kingdom
-
University at BuffaloTeva Pharmaceuticals USACompleted
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Opexa Therapeutics, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
University at BuffaloWithdrawn
-
University at BuffaloCharles University, Czech Republic; General University Hospital, PragueCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingPathologic Processes | Multiple Sclerosis | Sclerosis | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Autoimmune DiseasesUnited Kingdom
-
University Hospitals of North Midlands NHS TrustActive, not recruiting
-
BayerCompletedMultiple SclerosisGermany, Austria, United Kingdom, Israel, Belgium, Finland
-
BiogenAbbVieTerminatedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy, United States, Canada, Germany, Puerto Rico
-
Providence Health & ServicesCompletedRelapsing Remitting Multiple SclerosisUnited States